Search Browse Earnings

PepGen Inc. — SlamSEC

PepGen Inc.

Nasdaq:PEPG

Pharmaceutical Preparations·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Mcarthur James G

CFO

Donnelly Noel

Revenue

—

Adj. EBITDA

-$96.2M

FY 2025

Net Income

-$90.0M

FY 2025

EPS (Diluted)

-$2.85

FY 2025

Stock Price

$5.57

+1.2%

2026-03-09

52W Range

$0.88 – $7.80

P/E Ratio

-2.0x

Market Cap

$385.0M

Cash

$49.4M

FY 2025

Total Debt

—

Net Cash

$49.4M

Enterprise Value

$335.6M

Debt / EBITDA

0.5x

FY 2025

EV / EBITDA

-3.5x

Employees

—